Gottfried Schlaug to Thrombolytic Therapy
This is a "connection" page, showing publications Gottfried Schlaug has written about Thrombolytic Therapy.
Connection Strength
0.362
-
Alsop DC, Makovetskaya E, Kumar S, Selim M, Schlaug G. Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke. Stroke. 2005 Apr; 36(4):746-50.
Score: 0.209
-
Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Schlaug G, Bammer R, Marks MP, Albers GW. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke. 2008 Aug; 39(8):2257-63.
Score: 0.066
-
Selim M, Kumar S, Fink J, Schlaug G, Caplan LR, Linfante I. Seizure at stroke onset: should it be an absolute contraindication to thrombolysis? Cerebrovasc Dis. 2002; 14(1):54-7.
Score: 0.042
-
Mehdiratta M, Schlaug G, Kumar S, Caplan LR, Selim M. Reducing the delay in thrombolysis: is it necessary to await the results of renal function tests before computed tomography perfusion and angiography in patients with code stroke? J Stroke Cerebrovasc Dis. 2008 Sep; 17(5):273-5.
Score: 0.017
-
Lansberg MG, Thijs VN, Hamilton S, Schlaug G, Bammer R, Kemp S, Albers GW. Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Stroke. 2007 Jun; 38(6):1826-30.
Score: 0.015
-
Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke. 2005 Jul; 36(7):1447-51.
Score: 0.013